| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 14/12/2009 | 22:50 | Marketwired | Pharmacom Biovet, Inc. Adds New Management | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 12/08/2009 | 15:00 | Marketwired | Pharmacom Biovet Announces No Reverse Split | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 05/08/2009 | 14:56 | Marketwired | PharmaCom BioVet, Inc. Announces Plan for Asset Sale With Dividend to Shareholders | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 08/07/2009 | 14:31 | Marketwired | PharmaCom BioVet Establishing a Proprietary Canine DLA Registry | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 11/06/2009 | 14:31 | Marketwired | PharmaCom BioVet, Inc. Begins to Review the Process to Potentially Receive Minor Use/Minor Species Drug Approval From FDA | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 04/06/2009 | 14:30 | Marketwired | PharmaCom BioVet to File With FDA in Order to Perform Clinical Trials | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 22/04/2009 | 21:50 | Marketwired | PharmaCom BioVet Receives "Target Price of 0.016" From Market Analysis Firm Market Advisors | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 01/04/2009 | 06:00 | Marketwired | PharmaCom BioVet, Inc. Announces Joint Venture Agreement for Veterinary Cancer Compound | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 16/03/2009 | 20:34 | Marketwired | PharmaCom BioVet, Inc. Comments on Speculation of Corporate Restructuring | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 11/03/2009 | 12:30 | Marketwired | PharmaCom BioVet, Inc. Expands On Strategic Alliances | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 10/03/2009 | 15:24 | Marketwired | PharmaCom BioVet, Inc. Provides Update On Corporate Development | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 09/01/2009 | 17:08 | Marketwired | PharmaCom BioVet, Inc. Announces Its Plans to Establish Its First Branded Veterinary Oncology Treatment Center in the Columbia, | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 22/12/2008 | 15:35 | Marketwired | PharmaCom BioVet, Inc. Announces Initial Locations for Its Branded Veterinary Oncology Treatment Centers | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 18/12/2008 | 15:15 | Marketwired | PharmaCom BioVet, Inc. Begins Nationwide Rollout of Advanced Veterinary Oncology Centers | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 18/11/2008 | 23:25 | Marketwired | PharmaCom BioVet, Inc. Announces Cancer Care Centers to Incorporate Significant Benefits of Lymphoma Blood Tests for Canine Canc | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 17/11/2008 | 22:15 | Marketwired | PharmaCom BioVet, Inc. Collaborates With PetScreen, LTD, Leading Innovator of Canine Cancer Early Detection | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 10/11/2008 | 14:36 | Marketwired | PharmaCom BioVet, Inc. to Provide Novel Canine Cancer Treatment Programs to Meet Exploding Pet Care Demand | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 24/10/2008 | 01:49 | Marketwired | / CORRECTION - PharmaCom BioVet, Inc. | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 21/10/2008 | 14:30 | Marketwired | PharmaCom BioVet, Inc. and IsoTherapeutics Group, LLC Announces Liquid Brachytherapy Planned for Canine Cancer Treatment Centers | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 15/10/2008 | 14:41 | Marketwired | PharmaCom BioVet, Inc. Introduces Novel Cancer Treatments in Partnership With IsoTherapeutics Group | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 08/10/2008 | 14:36 | Marketwired | PharmaCom BioVet, Inc. Announces World's First Dedicated Veterinary Canine Bone Marrow Transplant Center | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 07/10/2008 | 22:00 | Marketwired | PharmaCom BioVet, Inc. Announces Corporate Vision to Research, Treat and Compassionately Care for Companion Animals Afflicted Wi | USOTC:PHMB | PharmaCom BioVet Inc (CE) |